Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation-Reference-Cited by-同舟云学术

Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation

Published:2017-07-10 Issue:45 Volume:36 Page:6262-6271
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Nakatsuka T,Tateishi K,Kudo Y,Yamamoto K,Nakagawa H,Fujiwara H,Takahashi R,Miyabayashi K,Asaoka Y,Tanaka Y,Ijichi H,Hirata Y,Otsuka M^ORCID,Kato M,Sakai J,Tachibana M,Aburatani H,Shinkai Y,Koike K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/onc2017222.pdf

Reference53 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.

2. Forner A, Llovet JM, Bruix J . Hepatocellular carcinoma. Lancet 2012; 379: 1245–1255.

3. Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM . The genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology 2015; 149: 1226–1239.

4. Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet 2014; 46: 1267–1273.

5. Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM . Pathogenesis of hepatocellular carcinoma and molecular therapies. Curr Opin Gastroenterol 2009; 25: 186–194.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma;Scientific Reports;2024-07-04

2. The JMJD family of histone demethylase and their intimate links to cardiovascular disease;Cellular Signalling;2024-04

3. Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview;Clinical and Translational Oncology;2023-01-17

4. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway;Cellular Signalling;2023-01

5. Development and prognosis of hepatocellular carcinoma in patients with diabetes;Clinical and Molecular Hepatology;2023-01-01